Vancouver, BC and Malvern, PA, October 4th, 2022 – Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, and Trice Medical, a global leader in minimally invasive small procedure technologies, are partnering to deliver the next generation of the world’s first platform that enables orthopedic physicians to use high-definition wireless ultrasound and a single-use handheld arthroscope on one tablet.
“As an orthopedist, my goal is to maximize my patient’s quality of life and minimize their disability in the safest and least invasive way; the ability to see clearly into the body is key to achieving the best results,” says Dr. Don Buford, a board-certified orthopedic surgeon specializing in sports medicine and regenerative medicine. “I simply cannot wait to be able to image the Trice needle arthroscope alongside the 3rd generation Clarius wireless ultrasound transducers in my practice on the same tablet. This is a partnership that will make any orthopedic clinician stop and say wow, that is really cool!”
Scheduled for release in early 2023, the new high-definition mi-ultra™ platform, powered by Clarius, will offer physicians two clear ways to dynamically evaluate the anatomy in diverse care settings. It combines mi-eye 3®, the world’s first FDA-cleared single-use 25° arthroscope with Clarius high-definition ultrasound, making them accessible through a single premier tablet.
“Our partnership with Clarius helps us take our mi-ultra platform to the next level of performance,” says Mark Foster, President and CEO of Trice Medical. “We’re excited about combining our single-use needle scopes with the best handheld ultrasound solution available on one simple, portable tablet. This is the imaging platform of the future, designed to enable therapeutic extremities procedures to be done in cost effective sites of service. Longer orthopedic procedures should be in the main operating rooms, but any procedure that takes longer to turn over the room than it does to complete the procedure is perfect for our platform.”
Clarius handheld wireless ultrasound scanners deliver high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost. The new Trice solution will be available with the Clarius L15 HD3, Clarius L20 HD3, L7 HD3 and the C3 HD3 scanners. Clarius is the only ultrasound company with an open software platform that enables easy integration with compatible medical innovations.
“We’re delighted that the Trice Medical team has chosen to integrate their ground-breaking arthroscope with Clarius high-definition wireless ultrasound,” says Ohad Arazi, CEO at Clarius Mobile Health. “By combining our efforts, we can bring innovations that deliver better patient care to market sooner.”
About Clarius Mobile Health
Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost.
Over two million high-definition scans have been performed using Clarius wireless handheld scanners. Clarius scanners are available in over 90 countries worldwide. Learn more at www.clarius.com.
Clarius Media Contact:
Marketing Vice President
Phone: +1 (866) 657-9243 ext. 221 | Direct: +1 (604) 260-7077
About Trice Medical
Trice Medical, headquartered in Malvern, PA, is a global leader in medical technologies with the purpose of building a great company that enhances quality of life. The company offers minimally invasive and portable solutions for diagnosing and treating distal extremities that can be performed in any care setting: the operating room, a procedure room, or the office. Trice Medical’s portfolio includes mi-tablet™ 3 High Resolution Imaging Platform; mi-eye 3®; mi-ultra™; Seg-WAY™ Endoscopic Release Systems; and Tenex Health TX® for treating chronic tendinopathy and bony prominences, including diabetic foot ulcers. More information is available at www.tricemedical.com.
Trice Media Contact:
Lyly Hoang Wight, Sr. Director, Global Marketing